HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Campath-1H-induced complete remission of chronic lymphocytic leukemia despite p53 gene mutation and resistance to chemotherapy.

AuthorsStephan Stilgenbauer, Hartmut Döhner
JournalThe New England journal of medicine (N Engl J Med) Vol. 347 Issue 6 Pg. 452-3 (Aug 08 2002) ISSN: 1533-4406 [Electronic] United States
PMID12167696 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Antineoplastic Agents
  • Alemtuzumab
Topics
  • Aged
  • Alemtuzumab
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm (therapeutic use)
  • Antineoplastic Agents (therapeutic use)
  • Chromosome Deletion
  • Chromosomes, Human, Pair 17 (genetics)
  • Female
  • Genes, p53
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell (drug therapy, genetics)
  • Point Mutation
  • Remission Induction
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: